Review
doi: 10.1021/jm901443h.
Through the "gatekeeper door": exploiting the active kinase conformation
Affiliations
- PMID: 20000735
- DOI: 10.1021/jm901443h
Item in Clipboard
Review
Through the "gatekeeper door": exploiting the active kinase conformation
J Med Chem.
.
No abstract available
Similar articles
-
A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.Drug Discov Today. 2007 Aug;12(15-16):622-33. doi: 10.1016/j.drudis.2007.06.008. Epub 2007 Aug 2. Drug Discov Today. 2007. PMID: 17706543 Review.
-
Bisubstrate inhibitors of protein kinases: from principle to practical applications.ChemMedChem. 2010 Jan;5(1):23-34. doi: 10.1002/cmdc.200900252. ChemMedChem. 2010. PMID: 19774589 Review.
-
The 'retro-design' concept for novel kinase inhibitors.IDrugs. 2010 Jul;13(7):457-66. IDrugs. 2010. PMID: 20582870 Review.
-
Strategies for the NMR-based identification and optimization of allosteric protein kinase inhibitors.Chembiochem. 2005 Sep;6(9):1607-10. doi: 10.1002/cbic.200500100. Chembiochem. 2005. PMID: 16028302 No abstract available.
-
Doing more than just the structure-structural genomics in kinase drug discovery.Curr Opin Chem Biol. 2008 Feb;12(1):40-5. doi: 10.1016/j.cbpa.2008.01.042. Epub 2008 Feb 29. Curr Opin Chem Biol. 2008. PMID: 18267130 Review.
Cited by
-
Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies.BMC Chem. 2024 Feb 12;18(1):29. doi: 10.1186/s13065-024-01130-5. BMC Chem. 2024. PMID: 38347617 Free PMC article.
-
FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.J Biol Chem. 2013 Oct 4;288(40):29105-14. doi: 10.1074/jbc.M113.510933. Epub 2013 Aug 19. J Biol Chem. 2013. PMID: 23960073 Free PMC article.
-
PKIDB: A Curated, Annotated and Updated Database of Protein Kinase Inhibitors in Clinical Trials.Molecules. 2018 Apr 15;23(4):908. doi: 10.3390/molecules23040908. Molecules. 2018. PMID: 29662024 Free PMC article.
-
c-Src binds to the cancer drug Ruxolitinib with an active conformation.PLoS One. 2014 Sep 8;9(9):e106225. doi: 10.1371/journal.pone.0106225. eCollection 2014. PLoS One. 2014. PMID: 25197973 Free PMC article.
-
p38α MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening.Molecules. 2015 Aug 31;20(9):15842-61. doi: 10.3390/molecules200915842. Molecules. 2015. PMID: 26334265 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
